Log In
Print this Print this

Morphomer Alpha synuclein

  Manage Alerts
Collapse Summary General Information
Company AC Immune S.A.
DescriptionAlpha synuclein (SNCA) inhibitor
Molecular Target Alpha synuclein (SNCA)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today